Sepsis Diagnostic Market Detailed In New Research Report 2021 | BioMérieux SA, Thermo Fisher Scientific, Abbott Laboratories, Roche Diagnostics AG

The global sepsis diagnostics market is expected to witness growth due to an increase in hospital-acquired infections over the forecast period. For instance, according to data from the Centers for Disease Control and Prevention (CDC), in 2019, there had been a 2% rise in ventilator-associated infections in the U.S. compared to 2018. Furthermore, according to the CDC's 2018 Annual Report for the Emerging Infections Program, around 15,000 cases of Clostridium difficile infection (CDI), a hospital-acquired infection, were recorded around 10 states in the U.S.

Major players in the global sepsis diagnostics market are involved in inorganic strategies such as acquisitions, collaborations, and so on. For instance, Curetis AG, a German molecular diagnostic company, for instance, signed into an agreement with Quaphaco, a Vietnam-based medical equipment provider, in February 2020, for the marketing of its product Unyvero for the diagnosis of lower respiratory tract diseases such as pneumonia. Furthermore, Curetis AG obtained 510k clearance for Unyvero from the U.S. Food and Drug Administration (FDA) in 2019. As pneumonia is among the causes of sepsis, market strategies for the distribution of these diagnostic systems are expected to fuel the growth of the global sepsis diagnostics market during the forecast period.

To Get more Business Statergies Request for Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/1166

On December 31, 2019, a COVID-19 outbreak was first detected in Wuhan, China. According to the World Health Organization's Coronavirus (COVID-19) Weekly Epidemiological Update, around 180 million cases and 3.9 million fatalities due to Coronavirus (COVID-19) were recorded globally up until June 27, 2021.

Due to rising number of COVID-19 cases and the necessity for early identification of sepsis associated with COVID-19 infection, the COVID-19 pandemic is expected to fuel the global sepsis diagnostics market growth over the forecast period. Furthermore, according to Global Sepsis Alliance data 2020, around 2-5 % of patients with severe COVID-19 infection exhibit sepsis symptoms such as multi-organ dysfunction within 8-10 days of hospitalization.

For instance, according to the Canadian Medical Association statistics 2020, sepsis is among the most common symptom linked with COVID-19, and the chance of developing COVID-19 associated sepsis is expected to be 10.4 %. As a result, researchers are conducting extensive research to create effective molecular diagnostic methods for the identification of sepsis and COVID-19.

Furthermore, the introduction of new products and regulatory approvals are expected to fuel the global sepsis diagnostics market growth over the forecast period. For instance, T2 Biosystems, Inc., a U.S.-based in vitro-diagnostic company, got U.S. Food and drug administration approval in May 2018 for its new product T2Bacteria Panel and is used to detect sepsis-causing bacteria in blood samples.

To Get Research PDF Brochure Here @ https://www.coherentmarketinsights.com/insight/request-pdf/1166

During the forecast period, the global sepsis diagnostics market is expected to register at a 9.6% CAGR (2021-2028). Due to increasing number of product launches, North America is expected to account for the largest share of the global sepsis diagnostics market during the forecast period (2021-2028). For instance, Beckman Coulter, a biomedical testing solutions provider based in the United States, introduced its latest DxH 690T hematology analyzer in May 2020, which can be used for the early diagnosis of sepsis.

Some of the key players contributing to the global sepsis diagnostics market are Immunexpress Inc., Abbott Laboratories, Danaher Corporation., Response Biomedical Corporation, Luminex Corporation, T2 Biosystems, Bruker Corporation, Thermo Fisher Scientific Becton Dickinson Company, CytoSorbents Corporation, EKF Diagnostics, Roche Diagnostics AG, BioMérieux SA, and Axis-Shield Diagnostics

To Direct Purchase this Research Report – https://www.coherentmarketinsights.com/insight/buy-now/1166

Contact US:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.